Article ID Journal Published Year Pages File Type
900966 Archives of Clinical Neuropsychology 2007 12 Pages PDF
Abstract

In this article we review studies in which Automated Neuropsychological Assessment Metrics (ANAM) measures were used to screen for impairment in various clinical populations. These clinical groups include patients with multiple sclerosis, systemic lupus erythematosus, Parkinson's disease, Alzheimer's dementia, acquired brain injury, and migraine headache. Data are also presented from a group of outpatient referrals unselected with respect to clinical condition. Findings support the use of ANAM as a screening procedure for identifying the impaired patient.

Related Topics
Health Sciences Medicine and Dentistry Psychiatry and Mental Health
Authors
, , , , ,